. Author manuscript; available in PMC: 2023 Jul 27.

Published in final edited form as: Cancer. 2017 Dec 6;124(6):1269–1278. doi: 10.1002/cncr.31174

Table 2. Comparison of coronary procedure rates and cardiovascular medications prescribed between cancer survivors and non-cancer patients, using adjusted Modified Poisson regression.

Outcomes	Cancer survivors vs non-cancer patients†
Outcomes	Adjusted RR (95% CI)	P-value
Coronary procedure within 30 days of AMI
Coronary angiography	0.98 (0.96-1.01)	0.23
PCI	0.98 (0.94-1.02)	0.29
CABG surgery	0.93 (0.85-1.02)	0.11
Medications prescribed within 90 days of AMI
Clopidogrel	0.98 (0.95-1.00)	0.05
ACEi/ARB	0.98 (0.97-0.99)	0.0015
Spironolactone	0.98 (0.92-1.04)	0.50
β-blockers	0.99 (0.98-1.00)	0.21
CCB	1.00 (0.97-1.03)	0.87
Lipid lowering agents	0.96 (0.95-0.98)	<0.0001
Diuretics	0.98 (0.96-1.01)	0.17
Nitrates	1.00 (0.99-1.01)	0.73
Oral anticoagulants	0.93 (0.89-0.97)	0.0003

Abbreviations: ACEi, angiotensin converting enzyme inhibitor; ADG, aggregated disease groups; AMI, acute myocardial infarction; ARB, angiotensin II receptor blocker; CABG, coronary artery bypass graft surgery; CCB, calcium channel blocker; HF, heart failure; PCI, percutaneous coronary intervention; RR, relative risk.